ClinicalTrials.Veeva

Menu

The Patient Expectation in Dry Needling and Analgesia

U

University of Alcala

Status

Completed

Conditions

Neck Pain

Treatments

Procedure: Dry needling with positives expectation
Procedure: Dry needling with neutral expectation

Study type

Interventional

Funder types

Other

Identifiers

NCT03673319
CEI18/087

Details and patient eligibility

About

This study will evaluate placebo mechanisms related to dry needling(DN) trying to determinate whether an additive effect occurs when DN is provided with an instructional set known to enhance placebo analgesia. External manipulation of patient expectation for receiving DN will be performed, in a similar way as has been already done in studies investigating the influence of expectation on spinal manipulative therapy interventions. The main purpose of this study will be therefore to determine, for the first time, how subjects' expectation about the effect of DN influences the resultant hypoalgesia. Analgesic effects of DN will be assessed using the conditioned pain modulation (CPM) paradigm, which has not been previously evaluated in relation to DN.

Full description

Just before DN intervention, participants will receive a positive or a neutral expectation instructional set regarding effects of a DN technique on pain perception. This instructional set will be randomly allocated to each patient.

Participants in the positive expectation group will be told that DN procedure: "is a very effective form of treatment used to treat neck-shoulder pain and it is expected to reduce your perception of pressure pain". Participants in the neutral expectation group will be told that DN procedure: "is a form of treatment used to treat neck-shoulder pain that has unknown effects on your perception of pressure pain".

DN intervention An experienced and trained physical therapist will provide DN to all the subjects. This researcher will be blinded to the specific expectation instructional set the participant receives. Participants will receive one session of DN treatment for the active Myofascial Trigger Points(MTrP) located at the upper trapezius muscle. They will be placed in a prone position on the examination table. Solid filament needles of 0.30 mm diameter and 40 mm length will be used. The needle will be inserted into the skin over the palpated MTrP using pincer palpation, and slowly advanced perpendicularly until it reaches the MTrP and a twitch response is elicited.

Enrollment

60 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • neck pain (≥3 months of duration)
  • VAS of 4-5 of pain.
  • Presence of at least one active MTrP located at the upper trapezius.

Exclusion criteria

  • Patients with previous cervical spine or shoulder surgery.
  • Cervical spine radiculopathy or myelopathy.
  • Systemic disease.
  • Fibromyalgia.
  • Pregnancy.
  • Using sedative drugs.
  • Needle phobia.
  • Bleeding disorder.
  • anticoagulant medication.
  • Previous experience with DN for myofascial pain.
  • Skin lesion and infection or inflammatory oedema at the MTrPs site

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

60 participants in 2 patient groups

Positive expectative
Experimental group
Description:
Participants in the positive expectation group will be told that DN procedure: "is a very effective form of treatment used to treat neck-shoulder pain and it is expected to reduce your perception of pressure pain"
Treatment:
Procedure: Dry needling with positives expectation
Neutral expectatives
Experimental group
Description:
Participants in the neutral expectation group will be told that DN procedure: "is a form of treatment used to treat neck-shoulder pain that has unknown effects on your perception of pressure pain"
Treatment:
Procedure: Dry needling with neutral expectation

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems